In VivoDevice Transactions Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. ( See Exhibit 1. ) Late-stage venture capital rounds represented most of
ScripFinancings During the third quarter of 2015, start-up companies raised a total of $2.57 billion, $39 million less than last quarter. Biopharma companies pulled in an impressive $2.38 billion, 53% resu
In VivoExhibit 1 Top Alliances In August 2015 (Potential Deal Value in $m) *Potential deal value is the sum of up-front fees plus pre-commercialization money. Strategic Transactions Exhibit 2 Top Mergers & A